Gleason W A, Grimme N L, Avioli L V, Alpers D H
Calcif Tissue Int. 1979 Jul 3;27(3):205-10. doi: 10.1007/BF02441187.
In order to assess the usefulness of intestinal biopsies as indicators of end-organ responsiveness to vitamin D in uremic patients, calcium binding activity and calcium binding protein (CaBP) content were measured in intestinal biopsies from 12 uremic patients (glomerular filtration rate less than 5.0 ml/min) and 12 adult controls. Values for both were found to vary with the site of biopsy, highest values being obtained in the duodenal bulb, with lower values distally. Values for activity correlated with values for CaBP content in both normals and uremics and no difference was observed between groups. Levels of calcium binding activity and content of CaBP did not correlate with serum immunoreactive parathormone levels, but were directly related to circulating 25-hydroxycholecalciferol (25-OHD) levels. The data show that intestinal CaBP is normal in activity, quantity, and affinity for calcium in malabsorbing uremic patients, and are consistent with the hypothesis that calcium malabsorption in uremia is unrelated to deficiency of intestinal calcium binding protein.
为了评估肠道活检作为尿毒症患者终末器官对维生素D反应性指标的有用性,我们测定了12例尿毒症患者(肾小球滤过率小于5.0 ml/min)和12例成年对照者肠道活检组织中的钙结合活性和钙结合蛋白(CaBP)含量。发现两者的值均随活检部位而变化,十二指肠球部的值最高,越向远端越低。正常人和尿毒症患者中,活性值与CaBP含量值相关,两组间未观察到差异。钙结合活性水平和CaBP含量与血清免疫反应性甲状旁腺激素水平无关,但与循环中的25-羟胆钙化醇(25-OHD)水平直接相关。数据表明,在吸收不良的尿毒症患者中,肠道CaBP在活性、数量和对钙的亲和力方面均正常,这与尿毒症中钙吸收不良与肠道钙结合蛋白缺乏无关的假说一致。